CN108351328A - 一种逆向分析鉴定中药有效成分的方法 - Google Patents

一种逆向分析鉴定中药有效成分的方法 Download PDF

Info

Publication number
CN108351328A
CN108351328A CN201680003852.3A CN201680003852A CN108351328A CN 108351328 A CN108351328 A CN 108351328A CN 201680003852 A CN201680003852 A CN 201680003852A CN 108351328 A CN108351328 A CN 108351328A
Authority
CN
China
Prior art keywords
patient
active ingredient
analysis
medicine
chinese herbs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680003852.3A
Other languages
English (en)
Chinese (zh)
Inventor
张坚
张坚一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN108351328A publication Critical patent/CN108351328A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4854—Diagnosis based on concepts of alternative medicine, e.g. homeopathy or non-orthodox
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/90—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to alternative medicines, e.g. homeopathy or oriental medicines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Primary Health Care (AREA)
  • Data Mining & Analysis (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Artificial Intelligence (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Evolutionary Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Physiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
CN201680003852.3A 2015-03-13 2016-03-03 一种逆向分析鉴定中药有效成分的方法 Pending CN108351328A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562177349P 2015-03-13 2015-03-13
US62/177,349 2015-03-13
US14/866,924 2015-09-26
US14/866,924 US20160085941A1 (en) 2015-03-13 2015-09-26 Method of Discovery of Effective Components in Herbals Based on Evidences by Reversed-directed Analysis
PCT/US2016/020789 WO2016148936A1 (en) 2015-03-13 2016-03-03 Method of discovery of effective components in herbals based on evidences by reversed-directed analysis

Publications (1)

Publication Number Publication Date
CN108351328A true CN108351328A (zh) 2018-07-31

Family

ID=55525998

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680003852.3A Pending CN108351328A (zh) 2015-03-13 2016-03-03 一种逆向分析鉴定中药有效成分的方法

Country Status (6)

Country Link
US (1) US20160085941A1 (https=)
EP (1) EP3268926A4 (https=)
JP (1) JP2018508084A (https=)
CN (1) CN108351328A (https=)
AU (1) AU2016233772A1 (https=)
WO (1) WO2016148936A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118671248A (zh) * 2024-08-23 2024-09-20 山东齐都药业有限公司 逆向分析聚原酸酯原料的方法及其应用

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102376173B1 (ko) * 2019-12-27 2022-03-21 한국식품연구원 식치 정보의 관리 방법 및 장치

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009837A1 (en) * 1997-08-28 1999-03-04 Cv Technologies Inc. Chemical and pharmacological standardization of herbal extracts
JP2001357131A (ja) * 2000-06-12 2001-12-26 Kanai Tokichi Shoten:Kk 通信ネットワークを介して漢方薬の処方を提供する方法
US20050283385A1 (en) * 2004-06-21 2005-12-22 The Permanente Medical Group, Inc. Individualized healthcare management system
JP2008097154A (ja) * 2006-10-06 2008-04-24 Fujitsu Ltd 相互作用分析プログラムおよび相互作用分析装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113907A (en) * 1997-04-15 2000-09-05 University Of Southern California Pharmaceutical grade St. John's Wort
JPH11193240A (ja) * 1997-12-26 1999-07-21 Meiji Milk Prod Co Ltd 脂質代謝改善組成物
CA2672408C (en) * 2007-03-30 2019-07-23 9898 Limited Pharmacokinetic and pharmacodynamic modelling and methods for the development of phytocompositions or other multi-component compositions
JP2013012025A (ja) * 2011-06-29 2013-01-17 Fujifilm Corp 診療支援システムおよび方法、並びに、プログラム
CN103065066B (zh) * 2013-01-22 2015-10-28 四川大学 基于药物组合网络的药物联合作用预测方法
US20150339442A1 (en) * 2013-12-04 2015-11-26 Mark Oleynik Computational medical treatment plan method and system with mass medical analysis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009837A1 (en) * 1997-08-28 1999-03-04 Cv Technologies Inc. Chemical and pharmacological standardization of herbal extracts
JP2001357131A (ja) * 2000-06-12 2001-12-26 Kanai Tokichi Shoten:Kk 通信ネットワークを介して漢方薬の処方を提供する方法
US20050283385A1 (en) * 2004-06-21 2005-12-22 The Permanente Medical Group, Inc. Individualized healthcare management system
JP2008097154A (ja) * 2006-10-06 2008-04-24 Fujitsu Ltd 相互作用分析プログラムおよび相互作用分析装置

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
刘元总 主编: "《临床药物学基础》", 30 June 2014 *
刘小平 主编: "《制药工程专业导论》", 31 August 2009 *
彭双清 主编: "《药物安全性评价关键技术》", 31 October 2013 *
李占双 编著: "《近代分析测试技术》", 30 June 2009 *
郭玉娟 主编: "《药事管理与法规》", 31 March 2012 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118671248A (zh) * 2024-08-23 2024-09-20 山东齐都药业有限公司 逆向分析聚原酸酯原料的方法及其应用
CN118671248B (zh) * 2024-08-23 2024-12-03 山东齐都药业有限公司 逆向分析聚原酸酯原料的方法及其应用

Also Published As

Publication number Publication date
JP2018508084A (ja) 2018-03-22
EP3268926A1 (en) 2018-01-17
EP3268926A4 (en) 2018-12-05
US20160085941A1 (en) 2016-03-24
WO2016148936A8 (en) 2017-03-30
WO2016148936A1 (en) 2016-09-22
AU2016233772A1 (en) 2017-08-17

Similar Documents

Publication Publication Date Title
Liu et al. Baclofen for alcohol withdrawal
Savla et al. Tea tree oil for Demodex blepharitis
Hsu et al. Symptom cluster trajectories during chemotherapy in breast cancer outpatients
Kearney et al. Pharmacological treatments for Friedreich ataxia
Siemens et al. Pharmacological interventions for pruritus in adult palliative care patients
Pastor et al. Specific EEG encephalopathy pattern in SARS-CoV-2 patients
Mann-Salinas et al. Novel predictors of sepsis outperform the American Burn Association sepsis criteria in the burn intensive care unit patient
Cochrane Haematology Group et al. Antibiotics for the treatment of COVID‐19
Lynch et al. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia
Hegerl et al. Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm
Xander et al. Pharmacological interventions for pruritus in adult palliative care patients
Cristea et al. Biological markers evaluated in randomized trials of psychological treatments for depression: a systematic review and meta-analysis
Anderson et al. Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life
Chen et al. Mapping normative muscle health metrics across the aging continuum: a multinational study pooling data from eight cohorts in Japan, Malaysia and Taiwan
Hicks et al. Effectiveness of pharmacotherapy for depression after adult traumatic brain injury: An umbrella review
Xu et al. Non-linear association between serum spermidine and mild cognitive impairment: Results from a cross-sectional and longitudinal study
M'Buyamba-Kabangu et al. Efficacy of newer versus older antihypertensive drugs in black patients living in sub-Saharan Africa
Arnison et al. Electroconvulsive therapy in the oldest-old patients with depression: response and remission rates, prognostic factors, adverse events and mortality
CN108351328A (zh) 一种逆向分析鉴定中药有效成分的方法
González-Álvarez et al. The association between pressure pain thresholds, conditioned pain modulation, clinical status, and sleep quality in fibromyalgia patients: a clinical trial secondary analysis
Park et al. Effects of Gyejibongnyeong-hwan on dysmenorrhea caused by blood stagnation: study protocol for a randomized controlled trial
Martins et al. Relationship between heart rate variability and functional fitness in breast cancer survivors: a cross-sectional study
Narendran et al. Imaging cortical dopamine transmission in cocaine dependence: a [11C] FLB 457–amphetamine positron emission tomography study
Bagheri et al. The effect of spiritual education on anxiety, depression and glycemic control in type 2 diabetic patients: a randomized controlled study
George et al. A Comprehensive Assessment of Pain Among Haemodialysis Patients: A Cross-sectional Study

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180731